AZN

#5321
AstraZeneca PLC - American Depositary Shares
185.7 1 USD
-0.15%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
184.74
185.75
년간 변동
68.62
212.71
일일 변동
-0.15%
월간 변동
-1.47%
6달 변화
+99.80%
년간 변동율
+161.27%
이전 종가
185.9 8
Open
184.8 6
저가
184.7 4
High
185.7 5
양
822
전체 차트 열기 Full chart

Financials

개요 성명 통계 배당금
4분기 연간
손익계산서 대차대조표 현금 흐름
값 Q4, 24Q4, 25 TTM

AstraZeneca PLC - American Depositary Shares

AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, UK; Gothenburg, Sweden; and Gaithersburg, Maryland, US. AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje.

뉴스